
A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
CMS implemented the Categorical Adjustment Index as part of the Medicare Advantage and Part D Star Rating Program in 2017. These analyses informed its development. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.
Centrally assisted collaborative telecare is a cost-effective strategy relative to usual care for treating posttraumatic stress disorder and depression in the Military Health System.
Published: April 10th 2025 | Updated:
Published: February 15th 2018 | Updated:
Published: September 7th 2018 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.